|
J Biol Chem, Vol. 273, Issue 17, 10777-10783, April 24, 1998
Bax in Murine Thymus Is a Soluble Monomeric Protein That Displays
Differential Detergent-induced Conformations*
Yi-Te
Hsu and
Richard J.
Youle
From the Biochemistry Section, Surgical Neurology Branch, NINDS,
National Institutes of Health, Bethesda, Maryland 20892
 |
ABSTRACT |
Bcl-2, Bcl-XL, and
Bax are members of the Bcl-2 family that play important roles in
apoptosis regulation. These proteins are believed to be membrane-bound
and to regulate apoptosis through formation of homo- and heterodimers.
However, we recently found by subcellular fractionation that whereas
Bcl-2 is predominantly a membrane protein as previously reported, Bax
and a significant fraction of Bcl-XL are soluble in
thymocyte and splenocyte extracts. In addition, we have demonstrated
that the ability of Bax to form dimers appears to be a
detergent-induced phenomenon that coincides with a detergent-induced
conformational change. We have further investigated the tertiary and
quaternary states of Bax in the presence of various detergents.
Detergents such as Triton X-100 and Triton X-114 readily enable Bax
hetero- and homodimerization. However, other detergents such as
polydocanol, W-1, octyl glucoside, dodecyl maltoside, Tween 20, and
sodium cholate allow varying degrees of Bax hetero- and
homodimerization. Detergents such as 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (Chaps)
and Brij 35 allow neither hetero- nor homodimer formation. Immunoprecipitation analysis with the conformation-sensitive antibody uBax 6A7 revealed that whereas Triton X-100 readily exposes the N-terminal Bax epitope (amino acid 13-19), only limited exposure of
the epitope occurs in Triton X-114, polydocanol, dodecyl maltoside, and
sodium cholate, and no exposure of this epitope was observed in W-1,
Chaps, octyl glucoside, Tween 20, and Brij 35. Moreover, we could not
detect any proteins associated with the cytosolic form of Bax based on
immunopurification of this protein. Sephacryl S-100 gel filtration
chromatography analysis of the cytosolic Bax indicated that this
protein is monomeric and displays an apparent molecular mass of 25 kDa.
Induction of apo-ptosis which causes the insertion of the soluble
form of Bax into membranes did not result in appreciable
Bax/Bcl-XL, Bax/Bcl-2 or Bax/Bax dimer formation as
determined by cross-linking studies. Further analysis of Bax after
apoptosis induction by immunoprecipitation in the presence of Chaps
also revealed no significant heterodimer formation. In conclusion, Bax
displays several distinct states in different detergents that expose
defined regions of the protein. In addition, these results suggest that
mechanisms other than the simple dimerization among members of the
Bcl-2 family may be required for the regulation of apoptosis.
 |
INTRODUCTION |
Apoptosis is a natural cell elimination process that occurs widely
among multicellular organisms. Members of the Bcl-2 family including
Bcl-2, Bcl-XL, and Bax represent some of the most well known regulators of this process. Bax was first described as a pro-apoptotic protein that can bind and counteract the pro-survival function of Bcl-2 (1). Overexpression of Bax in transfected mammalian
cells in many cases makes the cells more susceptible to apoptosis
induced by external stimuli (for reviews see refs. 2 and 3), whereas
only in some isolated cases it suppresses cell death (4, 5). Expression
of Bax in fission yeast, however, has been reported to directly induce
either growth arrest or cell death (6-10).
Like Bcl-2 and Bcl-XL, Bax has three highly conserved
regions known as BH1, BH2, and BH3 domains. The BH3 domain of Bax has been reported to be crucial for dimer formation (11). Based on yeast
two-hybrid select systems and/or immunoprecipitation studies, it has
been reported that Bax can form homodimers (1) or heterodimers with
Bcl-2, Bcl-XL, and Bid (1, 12-14). It can also form
heterodimers with adenovirus-encoded Bcl-2 homolog E19 kD (15-17) and
herpesvirus saimiri-encoded Bcl-2 homolog ORF16 (18) but not with a
Bcl-2 homolog KSbcl-2 encoded by herpesvirus 8 (19). In addition to
these dimerization domains, Bax also has a predicted membrane spanning
segment at its C-terminal end. In Bcl-2, this C-terminal hydrophobic
region is responsible for anchoring this protein to membranes of
various organelles including mitochondria, endoplasmic reticulum, and
nuclei (20-22). Based on the presence of this hydrophobic region and
the propensity of Bax to form heterodimers with Bcl-2, it was believed
that Bax co-localizes with Bcl-2 in membranes. However, recently,
several studies have shown that Bax is predominantly a soluble protein in thymocytes, splenocytes, and HL-60 promyelocytic leukemia cells (23,
24).
Functional analysis of Bax by knock-out studies indicate that this
protein is essential for spermatogenesis (25, 26). In a double
knock-out system, a deficiency in Bax prevents an increased cell death
in the immature neurons of Bcl-XL knock-out mice (27). Bax
has been also implicated in anti-viral defense in promoting cell death
in virally infected cells (28). In addition, Bax has been described as
a tumor suppressor (29), and in certain cases of human colorectal
cancer, frameshift mutations were found in the gene encoding Bax (30,
31).
Physiologically, Bax plays the role of sensitizing cells to apoptosis.
However, little is known about the molecular basis by which Bax
promotes cell death. One hypothesis, known as the dimer rheostat model,
suggests that the formation of Bax homodimers promotes cell death, and
in healthy living cells, the formation of Bax homodimers were prevented
by Bax heterodimerization with the prosurvival factors Bcl-2 and
Bcl-XL (1, 32). However, several recent mutagenesis studies
show that dimerization may not be essential for the regulation of
apoptosis (33-35). Furthermore, we found that the cytosolic Bax in
murine thymocytes undergoes a detergent-induced conformational change
that is associated with the propensity of this protein to form either
homodimers or heterodimers with Bcl-2 and Bcl-XL (24). In
this paper we have explored the epitope exposure and dimerization of
the cytosolic and membrane-bound Bax and identified several different
conformational states of this protein in the presence of various types
of detergents.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Synthetic peptides were purchased from Peptide
Technologies Corp. Imject maleimide-activated keyhole limpet hemocyanin
was obtained from Pierce. PEG 4000, fetal bovine sera, and
hypoxanthine/aminopterin/thymidine medium were from Life Technologies,
Inc. Iscove's medium was from Biofluid. Disuccinimidyl glutarate
(DSG)1 and
dithiobis(succinimidyl propionate) (DSP) cross-linkers were from
Pierce. Fractogel EMD TMAE-650M and AF-heparin-650M beads were bought
from EM Separations Technology and TosoHaas, respectively. SPOTs
peptides were obtained from Genosys. Sheep anti-mouse immunoglobulin peroxidase conjugate and ECL Western blotting detection kit were purchased from Amersham Pharmacia Biotech. Bolton-Hunter reagent was
from NEN Life Science Products. Immobilon membranes were from Millipore. All other reagents were obtained from Sigma.
Generation of Monoclonal Antibodies--
New anti-Bax monoclonal
antibodies were generated by immunizing mice with keyhole limpet
hemocyanin conjugated to peptides corresponding to amino acids 3-16 of
rat Bax (CGSGDHLGGGGPTSS) and amino acids 43-62 of mouse Bax
(PELTLEQPPQDASTKKLSEC). Splenocytes from immunoreactive mice were fused
by PEG 4000 to murine NS-1 myeloma cells and selected with
hypoxanthine/aminopterin/thymidine medium (24, 36). The anti-rat and
species-independent Bax antibodies were designated as rBax 1D1 and
uBax 2C8, respectively.
Immunoprecipitation Analysis of Bax--
Monoclonal antibodies
mBax 5B7, hBax 1F6, and uBax 6A7 were purified from ascites
fluids by ammonium sulfate precipitation and DEAE fractionation (24).
The purified antibodies were immobilized onto CNBr-activated Sepharose
4B at 2.5 mg of protein/ml packed beads (24, 37). For the
detergent-dependent Bax heterodimerization and uBax 6A7
antibody binding studies, murine thymocytes were subjected to hypotonic
lysis and Dounce homogenization at a cell density of 5 × 107/ml essentially as described previously (24). Soluble
protein extracts prepared from high speed centrifugation (130,000 × g) were adjusted to 150 mM NaCl either in the
absence of detergent or in the presence of 0.2% Triton X-100, Triton
X-114, polydocanol, W-1, Chaps, octyl glucoside, dodecyl maltoside,
Tween 20, Brij 35, or sodium cholate. The soluble extract (4.5 ml) was
mixed with 150 µl of mBax 5B7 or uBax 6A7 antibody beads
either in the absence or in the presence of appropriate detergents and allowed to incubate for 2 h. The unbound proteins were removed by
washing the beads twice with 10 ml of 10 mM Hepes, pH 7.4, and 150 mM NaCl or with the same buffer containing 0.2% of
the appropriate detergent. The bound proteins were then eluted off the
beads with 180 µl of 0.1 M acetic acid containing 0.2%
Triton X-100. The acid eluants were neutralized with 30 µl of 1 M Tris, pH 8.0.
For the study of Bax homodimerization, murine and rat thymocytes were
hypotonically lysed at a cell density of 1 × 108/ml.
The soluble proteins from the two cell types were prepared as described
above. The soluble extracts were mixed 1:1 and used for the
immunoprecipitation studies using the mBax 5B7 antibody Sepharose
beads in the presence of various detergents as described above.
Alternatively, immunoprecipitation of Bax was carried out from
detergent-solubilized whole cell lysate. Murine thymocytes were
solubilized in 10 ml of 10 mM Hepes, pH 7.4, 150 mM NaCl, and in the presence of 1% Triton X-100, Triton
X-114, polydocanol, Chaps, octyl glucoside, or dodecyl maltoside or
0.5% W-1 at a cell density of 5 × 107/ml. The lysate
was spun at 14,000 rpm in a Sorvall SA 600 rotor for 15 min to pellet
the nuclei and unsolubilized material. Bax complex was then
immunoprecipitated from 4.5 ml of the detergent-solubilized lysate with
150 µl of the mBax 5B7 antibody beads as described above.
For the study of Bax heterodimerization in dexamethasone-treated
thymocytes, murine thymocytes (7.5 × 107/ml) in
Iscove's medium were subjected to treatment with 2 µM dexamethasone for 4 h. The cells were then collected, spun down, and solubilized in 10 mM Hepes, pH 7.4, 150 mM
NaCl containing 1% Triton X-100 or Chaps. Immunoprecipitation of Bax
was carried out as described above. For the above immunoprecipitation
studies, all lytic, solubilization, and washing buffers contain
proteolytic inhibitors (25 µg/ml phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, and 1 µg/ml aprotinin) as described previously
(24).
Purification of Bax--
Soluble protein extracts from murine
thymocytes were prepared as described above except that the lysate was
prepared at a cell density of 1 × 108/ml. One hundred
and eighty ml of the extract in the presence of 38 mM NaCl
was loaded onto a 20-ml AF-heparin-650M column. Flow-through from the
column was collected and then loaded onto a 15-ml Fractogel EMD
TMAE-650M anion exchange column equilibrated in the same buffer. After
washing the column with 3 column volumes of the lysis buffer, Bax was
eluted off the column with 3 column volumes of the elution buffer (10 mM Hepes, pH 7.4, and 125 mM NaCl). The eluant
was then incubated with 0.5 ml of mBax 5B7 antibody beads for
3 h at 4 °C. The beads were then washed, and the bound Bax was
eluted off the beads with 0.1 M acetic acid containing
0.1% Triton X-100. Six fractions of 0.3-ml samples were collected and
neutralized with 40 µl of 1 M Tris, pH 8.0.
Gel Filtration Molecular Weight Sizing of Bax--
The relative
molecular weight of the cytosolic Bax was determined by gel filtration
over a Sephacryl S-100 column. Murine thymic soluble extract (1 × 108/ml) was loaded onto a TMAE 650M anion exchange column
as described above to concentrate the Bax. Half a ml of the 0.125 M NaCl eluant was then loaded onto the gel filtration
column (74 ml) equilibrated in 10 mM Hepes, pH 7.4, and 150 mM NaCl. One-ml fractions were collected and analyzed by
Western blotting with uBax 2C8 antibody. The peak fraction
containing murine Bax was assigned as the elution volume
(Ve) for the purpose of calculating its molecular weight. Blue dextran (2 × 103 kDa), bovine serum
albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa), and
ribonuclease A (13.7 kDa) were run separately as molecular weight
standards.
Cross-linking of Bax--
For whole cell cross-linking of
dexamethasone-treated thymocytes using membrane-permeable
cross-linkers, thymocytes were treated with 2 µM
dexamethasone for 4 h (23). The cells were washed once in PBS and
resuspended in PBS at a cell density of 2.5 × 107/ml.
Ten ml of the cell suspension were then incubated with 1 mM
DSP or DSG for 30 min on ice. The reaction was quenched with 10 mM Tris, pH 7.4, and 100 mM glycine buffer. The
cells were then spun down, and the cell pellet was resuspended in 2 ml
of 1% SDS. The samples were run on a 10% SDS-polyacrylamide gel in the absence of -mercaptoethanol and analyzed by Western
blotting.
Binding of Iodinated Antibodies to Thymocyte Membranes--
Ten
micrograms of anti-murine Bax 5B7, anti-human Bax 1F6, and
anti-universal Bax 6A7 monoclonal antibodies were iodinated with
Bolton-Hunter reagent according to the manufacturer's protocol. Murine
thymocytes were treated with dexamethasone for 4 h and subjected
to hypotonic lysis and Dounce homogenization at a cell density of
5 × 107/ml as described above. The lysate (0.5 ml)
was adjusted to 150 mM NaCl and incubated with 50 ng (2 µCi/µg) of iodinated antibodies either with or without the presence
of 50 µg of cold antibodies for 30 min on ice. The samples were then
subjected to ultracentrifugation at 61,000 rpm for 30 min in a TLA
120.1 rotor. The radioactivity of the membrane pellets was then
determined with a gamma counter.
SDS-Polyacrylamide Gel Electrophoresis and Western
Blotting--
SDS-polyacrylamide gel electrophoresis (12%
polyacrylamide gel unless specified) and Western blotting were carried
out as described previously (24). For immunoblotting analysis, the blots were probed with either mBax 5B7 (1:10 diluted culture fluid), uBcl-XL 2H12 (1:10 diluted culture fluid), mBcl-2 10C4 (1:10 diluted culture fluid), rBax 1D1 (1:10 diluted
culture fluid), or uBax 2C8 (1:20 diluted culture fluid) diluted in the blocking buffer for 45 min. The blots were then washed in PBS,
0.05% Tween 20 and incubated in blocking buffer containing 1:7000
diluted sheep anti-mouse immunoglobulin peroxidase for an additional 30 min. The blots were again washed in PBS, 0.05% Tween 20 and then in
PBS and visualized by ECL Western blotting detection kit.
 |
RESULTS |
Epitope Mapping of Anti-Bax Antibodies--
The N-terminal
epitopes of several anti-Bax monoclonal antibodies were determined by
peptide mapping (SPOTs) analysis of a nested set of peptides
corresponding to the N-terminal segments of Bax used for the generation
of antibodies. As shown in Fig. 1, the
binding specificity of mBax 5B7, hBax 1F6, and rBax 1D1
monoclonal antibodies lies within amino acids 7-14. The first 4 amino
acids within this particular region are distinct between mouse, human,
and rat and appear to account for the species specificity of these
antibodies. The epitope for the uBax 6A7 monoclonal antibody,
produced against a peptide sequence (amino acids 12-24) common to
murine, human, and rat Bax, was found within amino acids 13-19 which
partially overlaps with epitopes of the above-described species-specific antibodies.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Epitope mapping of anti-Bax antibodies.
The epitopes for the various anti-Bax monoclonal antibodies mBax
5B7, hBax 1F6, rBax 1D1, and uBax 6A7 were mapped by SPOTs
analysis. The amino acid residues within the antibody binding sites are
bracketed.
|
|
Detergent-dependent Selective Heterodimerization of Bax
with Bcl-2 and Bcl-XL--
The propensity of Bax to form
Bax/Bcl-2 and Bax/Bcl-XL heterodimers in the presence of
nonionic detergents Triton X-100 and Nonidet P-40 (24) led us to
investigate the effect of other detergents in the induction of this
process. Murine thymocytes were solubilized in either Triton X-100,
Triton X-114, polydocanol, W-1, Chaps, octyl glucoside, or dodecyl
maltoside. Immunoprecipitation of Bax was then carried out in the
presence of these detergents using mBax 5B7 monoclonal antibody
(Fig. 2). Detergents such as Tween 20, Brij 35, or sodium cholate failed to efficiently solubilize the
thymocytes, and therefore they were excluded from this experiment. The
immunoprecipitated samples were analyzed by Western blotting with uBax 2C8, mBcl-2 10C4, and uBcl-XL 2H12 monoclonal
antibodies for the detection of murine Bax, Bcl-2, and
Bcl-XL, respectively. As shown in Fig. 2, Triton X-100 and its related homolog Triton X-114 readily enable Bax/Bcl-2 and Bax/Bcl-XL heterodimer formation. Other detergents such as
octyl glucoside mediate Bax/Bcl-XL heterodimer formation
but allow much less Bax/Bcl-2 heterodimer. Meanwhile, detergents such
as polydocanol, W-1, and dodecyl maltoside enable only
Bax/Bcl-XL formation with a clear absence of Bax/Bcl-2
heterodimer. Finally the zwitterionic detergent Chaps allows neither
Bax/Bcl-2 nor Bax/Bcl-XL heterodimer formation. Addition of
0.1% SDS to the Triton X-100 solubilization buffer disrupts Bax/Bcl-2
heterodimer formation but does not affect Bax heterodimerization to
Bcl-XL (data not shown), suggesting that the interaction
between Bax and Bcl-XL is comparably stronger than that of
Bax and Bcl-2. Based on this study, it appears that different
detergents may induce different sets of conformational changes in Bax,
and perhaps in Bcl-2 and Bcl-XL as well, to facilitate the
differential heterodimerization of Bax with Bcl-2 or
Bcl-XL.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 2.
Detergent-dependent
heterodimerization of Bax with Bcl-2 and Bcl-XL.
Murine thymocytes were solubilized in the presence of Triton X-100,
Triton X-114, polydocanol, W-1, Chaps, octyl glucoside, and dodecyl
maltoside. Bax was immunoprecipitated from the detergent-solubilized
thymocyte lysates by mBax 5B7 antibody Sepharose beads. The
presence of Bax (lane b), Bcl-2 (lane d), and
Bcl-XL (lane f) in the immunoprecipitated
samples was detected by Western blotting analyses with mBax 5B7
(left), mBcl-2 10C4 (middle), and uBcl-XL 2H12 (right) monoclonal antibodies.
Lanes a, c, and e represent endogenous Bax,
Bcl-2, and Bcl-XL in murine thymocyte lysates,
respectively.
|
|
Effect of Detergent on the Homodimerization of Bax--
We have
previously reported that Bax homodimerization, like heterodimerization,
appears to be a detergent-dependent process (24). Since we
find Bax heterodimerization to be dependent upon the type of detergent
present, we set out to examine the effect of different detergents on
Bax homodimerization. Bax was immunoprecipitated from a mixture of the
soluble protein extracts of murine and rat thymocytes either in the
absence of detergent or in the presence of Triton X-100, Triton X-114,
polydocanol, W-1, Chaps, octyl glucoside, dodecyl maltoside, Tween 20, Brij 35, or sodium cholate. Murine Bax was immunoprecipitated from the
mixture by mBax 5B7 monoclonal antibody to examine its propensity
to dimerize with rat Bax. The immunoprecipitated samples were analyzed
by Western blotting with anti-murine Bax 5B7 and anti-rat Bax 1D1
monoclonal antibodies (Fig. 3,
top and middle). As revealed by Western blotting, mBax 5B7 antibody immunoprecipitated murine Bax under all
conditions. Homodimerization of murine Bax to rat Bax, as determined by
Western blotting with anti-rat Bax 1D1 antibody, occurs most readily in Triton X-100 and Triton X-114 (Fig. 3, middle, lanes e and
f) and is reduced in the presence of polydocanol and dodecyl
maltoside (Fig. 3, middle, lanes g and k). Bax
homodimers do not form in the absence of detergent (Fig. 3,
middle, lane d), as expected, nor in the presence of W-1,
Chaps, octyl glucoside, Tween 20, Brij 35, and sodium cholate (Fig. 3,
middle, lanes h, i, j, l, m, and n). To determine
if Bax heterodimerization with Bcl-XL occurs under similar
conditions, the above-described immunoprecipitated samples were
analyzed by Western blotting with uBcl-XL 2H12 antibody. The results indicate that Bax can differentially form heterodimers with Bcl-XL in the presence of most of these
detergents with the exception of Chaps and Brij 35 (Fig. 3,
bottom, lanes i and m). In the absence of
detergent, as previously reported (24), Bax does not heterodimerize
with Bcl-XL (Fig. 3, bottom, lane d). These
results suggest that the Bax homodimerization state is not only
dependent upon the type of detergent but also appears to be distinct
from its heterodimerization state.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Distinct states of Bax homo- and
heterodimerization induced by detergents. Immunoprecipitation of
Bax from a mixture of the soluble protein extracts of murine and rat
thymocytes was carried out using mBax 5B7 antibody Sepharose beads
either without (lane d) or in the presence of Triton X-100
(lane e), Triton X-114 (lane f), polydocanol
(lane g), W-1 (lane h), Chaps (lane
i), octyl glucoside (lane j), dodecyl maltoside
(lane k), Tween 20 (lane l), Brij 35 (lane
m), and sodium cholate (lane n). The protein samples
were analyzed by Western blotting with either mBax 5B7 (upper
panel), rBax 1D1 (middle panel), or uBcl-XL 2H12 (lower panel) monoclonal
antibodies. Lane a, soluble protein extract of murine
thymocytes; lane b, soluble protein extract of rat
thymocytes; and lane c, combined soluble protein extracts of
murine and rat thymocytes.
|
|
Detergent-dependent Exposure of the uBax 6A7
Antibody Epitope--
We have previously described the exposure of an
N-terminal epitope of Bax (amino acids 12-24), which contains the
binding site for the uBax 6A7 antibody, in the presence of Triton
X-100 and Nonidet P-40 (24). In order to further investigate the
conformation-dependent exposure of this epitope that
correlates with Bax hetero- and homodimerization and competes for
Bax-Bcl-XL heterodimer formation, we extended the
immunoprecipitation study with uBax 6A7 antibody in the presence of
various detergents. The immunoprecipitated samples were analyzed by
Western blotting with mBax 5B7 monoclonal antibody for the
detection of murine Bax bound to the 6A7 antibody. Whereas the uBax
6A7 antibody binds strongly to Bax in the presence of Triton X-100
(Fig. 4, top, lane c), a
decreased affinity was observed in the presence of Triton X-114,
polydocanol, and sodium cholate (Fig. 4, top, lanes d, e and
l), and only trace binding was observed in the presence of
dodecyl maltoside (Fig. 4, top, lane i). Bax did not bind to
the uBax 6A7 antibody either in the absence of detergent or in the
presence of W-1, Chaps, octyl glucoside, Tween 20, and Brij 35 (Fig. 4,
top, lanes b, f, g, h, j, and k). Thus, the
epitope for the 6A7 antibody (now mapped to amino acids 13-19), which
is normally buried, apparently adapts the exposed conformation only in
the presence of selected detergents.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
Detergent-dependent binding of
the conformation-sensitive anti-uBax 6A7 monoclonal antibody to
Bax. Anti-uBax 6A7 monoclonal antibody was used to
immunoprecipitate Bax from the soluble protein extract of murine
thymocytes (lane a) either in the absence of detergent
(lane b) or in the presence of Triton X-100 (lane
c), Triton X-114 (lane d), polydocanol (lane
e), W-1 (lane f), Chaps (lane g), octyl
glucoside (lane h), dodecyl maltoside (lane i),
Tween 20 (lane j), Brij 35 (lane k), or sodium
cholate (lane l). Western blotting analyses of the
immunoprecipitated samples were carried out with mBax 5B7 and uBcl-XL 2H12 monoclonal antibodies.
|
|
We have also previously reported that the 6A7 antibody binding site
competes with heterodimer formation (24). Here we examined the effect
of different detergents on this competitive process by analyzing the
6A7 antibody immunoprecipitated Bax samples for possible heterodimer
formation with Bcl-XL. As shown in the Western blot probed
with uBcl-XL 2H12 antibody, Bax immunoprecipitated in
the presence of Triton X-100, Triton X-114, polydocanol, and dodecyl
maltoside is not associated with cytosolic Bcl-XL (Fig. 4,
bottom Western, lanes c-e and i). Surprisingly,
Bax immunoprecipitated by the 6A7 antibody in the presence of sodium
cholate forms heterodimer with Bcl-XL (Fig. 4, bottom
Western, lane l). This suggests that the detergent environment by
which Bax is exposed to may greatly dictate the conformation undertaken
by this protein.
Purification and Molecular Weight Sizing of Bax--
Our recent
finding that Bax is a soluble protein prompted us to determine if Bax
in its cytosolic state is associated with any binding proteins. Bax was
purified from the murine thymocyte extract by sequential chromatography
through heparin, TMAE anion exchange, and anti-mouse Bax 5B7 antibody
columns. The initial step with heparin column removed a significant
quantity of cytosolic proteins without retaining Bax (Fig.
5, lanes b). The subsequent step by TMAE anion exchange chromatography retained the majority of
proteins while allowing Bax to elute at 0.125 M NaCl (Fig. 5, lane d). Incidentally, Bcl-XL elutes at a
salt concentration of between 0.3 and 0.5 M, further
suggesting that the cytosolic Bax is not associated with
Bcl-XL. Bax was purified from the TMAE column eluant by
anti-mouse Bax 5B7 antibody Sepharose beads. As shown in Fig. 5
(lane e), the purified Bax displays an apparent molecular
mass of 22 kDa, and it does not appear to be associated with any other
proteins.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Purification of Bax from murine
thymocytes. Murine Bax was purified from thymocyte soluble protein
fraction by heparin affinity, TMAE anion exchange, and mBax 5B7
immunoaffinity chromatography. The protein samples were analyzed by
SDS-polyacrylamide gel electrophoresis and stained with Coomassie Blue
or by Western blotting analysis with uBax 2C8 monoclonal antibody.
Lane a, soluble murine thymocyte extract; lane b,
flow-through from heparin column; lane c, flow-through from
TMAE anion exchange column; lane d, eluant from TMAE column;
lane e, eluant from mBax 5B7 antibody Sepharose
beads.
|
|
To confirm that the cytosolic Bax is a monomeric and not a dimeric or
multimeric protein, gel filtration chromatography was carried out on a
Sephacryl S-100 column using blue dextran, bovine serum albumin,
ovalbumin, chymotrypsinogen A, and ribonuclease A as molecular weight
standards. As shown in Fig. 6, the
apparent molecular mass of the murine thymic cytosolic Bax was
calculated to be 25 kDa. This suggests that murine Bax in healthy
thymocytes is a monomeric protein and does not appear to be bound with
any other proteins.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Gel filtration molecular weight sizing of
murine Bax. The relative molecular weight of murine thymocyte Bax
was determined by gel filtration over a Sephacryl S-100 column. Blue
dextran, bovine serum albumin, chymotrypsinogen A, and ribonuclease A
were used as standards. The Ve of Bax, as determined
by Western blotting, is 46 ml.
|
|
Effect of Apoptosis on Bax Dimer Formation and Exposure of the 6A7
Epitope--
Induction of apoptosis in murine thymocytes results in
the insertion of a significant fraction of Bax from the cytosol into membranes (23, 38). Thus it remained plausible that Bax inserts into
membranes and adopts the detergent-induced conformation to dimerize
with Bcl-2 and Bcl-XL. In order to determine if this insertion process resulted in the formation of Bax heterodimers with
Bcl-2 or Bcl-XL, we performed immunoprecipitation of Bax from dexamethasone-treated thymocytes in the presence of either Triton
X-100 or Chaps. As shown in Fig.
7A, the relative amount of
Bax/Bcl-2 and Bax/Bcl-XL heterodimers obtained from Bax
immunoprecipitation in the presence of Triton X-100 does not
significantly change before or after the induction of apoptosis (Fig.
7A, left). However, since Triton X-100 induces Bax dimer
formation, it is not possible to differentiate dimer formation
resulting from the detergent or the apoptosis.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 7.
Quaternary state of Bax during apoptosis.
A, immunoprecipitation of Bax was carried out with mBax
5B7 antibody from either healthy murine thymocytes (lanes a
and b) or thymocytes treated with dexamethasone (lanes
c and d). The study was carried out in the presence of
Triton X-100 (left column) or Chaps (right
column). The protein samples were probed by Western blotting with
uBax 2C8, mBcl-2 10C4, and uBcl-XL 2H12
monoclonal antibodies. Lanes a and c are
detergent-solubilized thymocyte lysates, and lanes b and
d are the immunoprecipitated samples. B, healthy
thymocytes (lanes b and c) and thymocytes treated
with dexamethasone (lanes d and e) were analyzed
by chemical cross-linking with DSG (lanes b and
d) or DSP (lanes c and e). The
cross-linked protein samples were analyzed by Western blotting with mBax 5B7 monoclonal antibody. Lane a is the uncross-linked
thymocyte sample.
|
|
Since Chaps can solubilize thymocytes without triggering Bax dimer
formation, we carried out immunoprecipitation of Bax from apoptotic
thymocytes using this detergent. We have first determined that the
presence of Chaps does not disrupt Bax heterodimer formation when used
in combination with Triton X-100 (data not shown). However, either
before or after induction of apoptosis (Fig. 7A, right), no
Bax heterodimers were found in Chaps-solubilized thymocyte lysate,
suggesting that Bax heterodimer formation does not occur during
apoptosis. We also investigated the exposure of the 6A7 antibody
epitope in the membrane-bound Bax. This was carried out by mixing the
apoptotic thymocyte lysate with various iodinated antibodies either in
the presence or absence of competing cold antibodies. As shown in Table
I, a significant binding of the 6A7
antibody was observed in apoptotic membranes of murine thymocytes, suggesting that this epitope may be exposed once Bax inserts into membranes.
We further examined the possibility of Bax dimer formation in membranes
during apoptosis by cross-linking of whole thymocytes with DSG and DSP.
Although the Coomassie Blue-stained gel showed extensive cross-linking
(data not shown), we failed to observe the formation of Bax dimers
(Fig. 7B). Similarly we did not detect any Bax dimer
formation in a cross-linking study of organelle membranes in HL-60
cells treated with staurosporine (data not shown). Nevertheless, it is
possible that the lysine residues that are primary sites for
cross-linking are not exposed in Bax. These studies suggest that the
formation of Bax dimer may not occur physiologically and that dimer
formation induced by nonionic detergents such as Triton X-100 and
Nonidet P-40 does not truly represent the state of Bax within
cells.
 |
DISCUSSION |
The pro-apoptotic factor, Bax, has been described as an integral
membrane protein that regulates apoptosis through the formation of
homo- or heterodimers (1, 32). However, we have shown here and in a
previous report (24) that in healthy murine thymocytes, Bax is a
soluble protein and is monomeric based on subcellular fractionation,
immunoaffinity purification, and gel filtration molecular weight sizing
analyses. In addition we have shown that the propensity of Bax to form
dimers lies with its conformational change induced by nonionic
detergents. In this report we have further examined Bax conformational
change induced by a variety of detergents with respect to its dimer
formation and the exposure of a conformation-sensitive epitope for the
6A7 antibody (24). As shown in Table II,
both the dimerization of Bax and the exposure of its 6A7 antibody
binding site appear to be highly dependent upon the type of
detergent.
View this table:
[in this window]
[in a new window]
|
Table II
Bax dimer formation and the exposure of the 6A7 antibody epitope in the
presence of different detergents
The relative extent of Bax dimerization and 6A7 antibody binding were
assigned as strong (+++), medium (++), weak (+), or none ( ).
|
|
Based on studies by site-directed mutagenesis, immunoprecipitation and
yeast two-hybrid select system, dimer formation among members of the
Bcl-2 family has been shown to be mediated through BH1 and BH2 domains
in pro-survival factors such as Bcl-2 and Bcl-XL (39) and
BH3 domains in pro-apoptotic factors such as Bax, Bak, Bid, Bik, Bad,
and Hrk (7, 11, 14, 40-43). However, the physiological role of these
dimer formations is still unclear. Whereas the majority of studies
suggest that these dimerization domains are essential for both the
dimer formation and the anti- or pro-apoptotic activities of these
proteins, a few studies have suggested that dimer formation may be
unrelated to the apoptosis regulatory activities of these proteins
(33-35). All these binding studies reported so far, however, were
carried out in the presence of Nonidet P-40. Our earlier finding of Bax
being a soluble protein (24) circumvented the need for the addition of
detergents. Our studies suggest that the dimeric state of Bax
correlates with a nonionic detergent-induced conformational change that
perhaps leads to the exposure of the BH3 domain of this protein and
perhaps the BH1 and BH2 domains of Bcl-2 and Bcl-XL as
well. Thus the relative ratio of Bax homodimers to Bax heterodimers
obtained by previous studies does not truly reflect the actual dimeric states of these proteins in cells but rather ones that are favored by
the specific conformation called for by the detergent chosen for the
experiment.
We have analyzed Bax dimerization and conformational changes with the
following three classes of detergents: nonionic with polyoxyethylene
(Nonidet P-40, Triton X-100, Triton X-114, polydocanol, W-1, Tween 20, and Brij 35) or sugar head groups (octyl glucoside and dodecyl
maltoside), zwitterionic (Chaps), and anionic (sodium cholate). Within
the polyoxyethylene subclass of non-ionic detergents, detergents with
alkylphenyl hydrophobic moieties (Nonidet P-40, Triton X-100, and
Triton X-114) more readily induce Bax dimer formation and the exposure
of the 6A7 antibody epitope as compared with those with alkyl
(polydocanol, W-1, and Brij 35) or acyl sorbitan ester (Tween 20)
groups. The length of the polyoxyethylene chains in detergents with
alkyl head groups also appears to play a determinant role. Whereas
polydocanol (n = 9) and W-1 (a mix of 64 parts
n = 10 and 36 parts n = 20) gave at
least some extent of Bax dimerization and 6A7 epitope exposure, Brij 35 (n = 23), despite having the same alkyl hydrophobic
group as polydocanol, fails to elicit either response. Alkyl glucosides
(octyl glucoside and dodecyl maltoside) gave varying degrees of Bax
dimers but with little or no 6A7 antibody epitope exposure.
The zwitterionic detergent Chaps that has both the bile salt
hydrophobic and sulfobetaine polar groups is the only detergent we
tested that can solubilize thymocytes but does not promote Bax dimer
formation or 6A7 antibody epitope exposure. In contrast, the bile salt
detergent sodium cholate, from which Chaps was derived, allows both the
heterodimer formation of Bax to Bcl-XL and the exposure of
the 6A7 epitope. However, Bax immunoprecipitated by the 6A7 antibody in
the presence of sodium cholate readily forms heterodimers with
Bcl-XL, whereas Bax immunoprecipitated by this antibody in
the presence of alkylphenyl-based detergents is not associated with
either Bcl-2 or Bcl-XL due to possible steric hinderance
(24). Thus the conformational change leading to the exposure of the 6A7
epitope by sodium cholate appears to be different from those induced by
Triton X-100, Triton X-114, and Nonidet P-40.
We have uncovered four major conformational states of Bax. In the first
state that pertains to the absence of detergent or the presence of
Chaps, Bax undertakes a conformation in which it neither dimerizes nor
exposes the 6A7 epitope. In the second state represented by exposure to
W-1 and Tween 20, Bax can undergo heterodimerization but not
homodimerization nor exposure of the 6A7 epitope. The third major state
can be typified by the sodium cholate-induced heterodimerization of Bax
and the exposure of the 6A7 epitope. The fourth state is best
represented by the one induced by Triton X-100, Triton X-114, and
Nonidet P-40 in which Bax can undergo both homo- and heterodimerization
and exposure of the 6A7 epitope. However, unlike the third state
induced by sodium cholate, the heterodimerization process induced by
alkylphenyl detergents competes with the binding of the 6A7 antibody.
So far we have not detected dimer formation in apoptotic thymocytes by chemical cross-linking or immunoprecipitation in the presence of Chaps.
However, we have detected some binding of the 6A7 antibody to the
apoptotic membranes. Thus, questions remain as to the actual state of
Bax conformation during apoptosis.
We have recently described the redistribution of Bax from the cytosol
into membranes during apoptosis (23, 38) and the importance of the
hydrophobic tail of Bax in promoting this insertion process (38).
Interestingly, the recent x-ray crystallographic analysis of
Bcl-XL indicates that this protein folds much like the
translocation domain of diphtheria toxin (44), which is capable of
forming pores for the translocation of its toxin domain (45).
Subsequently, it was shown that Bcl-2, Bcl-XL, and Bax can
form channels to allow ion conductivity (46-49). However, the recombinant protein samples from these studies lack the C-terminal hydrophobic tail, and during their preparation they were exposed to
Triton X-100, a detergent we described in our studies as having the
ability to alter the conformation of Bax. In our studies we have found
a conformation-dependent exposure of the 6A7 antibody epitope on Bax in apoptotic membranes but with no dimer formation. This
membrane-associated conformation appears to be intermediary of the ones
found in Chaps in which Bax neither dimerizes nor exposes its 6A7
epitope and in alkylphenyl detergents in which Bax dimerizes and
exposes its 6A7 epitope. Thus interesting challenges remain in defining
not only the molecular basis and consequence of Bax insertion but also
the conformational change associated with the insertion.
 |
ACKNOWLEDGEMENT |
We thank Pat Johnson for invaluable technical
assistance.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Biochemistry Section,
Surgical Neurology Branch, NINDS, National Institutes of Health, 10 Center Dr., Rm. 5D-37, Bethesda, MD 20892. E-mail: youle{at}helix.nih.gov.
1
The abbreviations used are: DSG, disuccinimidyl
glutarate; Chaps,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; PBS,
phosphate-buffered saline; DSP, dithiobis(succinimidyl propionate).
 |
REFERENCES |
-
Oltvai, Z. N.,
Milliman, C. L.,
and Korsmeyer, S. J.
(1993)
Cell
74,
609-619[CrossRef][Medline]
[Order article via Infotrieve]
-
Yang, E.,
and Korsmeyer, S. J.
(1996)
Blood
88,
386-401[Free Full Text]
-
Kroemer, G.
(1997)
Nat. Med.
3,
614-620[CrossRef][Medline]
[Order article via Infotrieve]
-
Middleton, G.,
Nuñez, G.,
and Davies, A. M.
(1996)
Development
122,
695-701[Abstract]
-
Oh, J. H.,
O'Malley, K. L.,
Krajewski, S.,
Reed, J. C.,
and Oh, Y. J.
(1997)
Neuroreport
8,
1851-1856[Medline]
[Order article via Infotrieve]
-
Greenhalf, W.,
Stephan, C.,
and Chaudhuri, B.
(1996)
FEBS Lett.
380,
169-175[CrossRef][Medline]
[Order article via Infotrieve]
-
Zha, H.,
Fisk, H. A.,
Yaffe, M. P.,
Mahajan, N.,
Herman, B.,
and Reed, J. C.
(1996)
Mol. Cell. Biol.
16,
6494-6508[Abstract]
-
Jürgensmeier, J. M.,
Krajewski, S.,
Armstrong, R. C.,
Wilson, G. M.,
Oltersdorf, T.,
Fritz, L. C.,
Reed, J. C.,
and Ottilie, S.
(1997)
Mol. Biol. Cell
8,
325-339[Abstract]
-
Manon, S.,
Chaudhuri, B.,
and Guérin, M.
(1997)
FEBS Lett.
415,
29-32[CrossRef][Medline]
[Order article via Infotrieve]
-
Tao, W.,
Kurschner, C.,
and Morgan, J. I.
(1997)
J. Biol. Chem.
272,
15547-15552[Abstract/Free Full Text]
-
Zha, H.,
Aimé-Sempé, C.,
Sato, T.,
and Reed, J. C.
(1996)
J. Biol. Chem.
271,
7440-7444[Abstract/Free Full Text]
-
Sato, T.,
Hanada, M.,
Bodrug, S.,
Irie, S.,
Iwama, N.,
Boise, L. H.,
Thompson, C. B.,
Golemis, E.,
Fong, L.,
Wang, H.-G.,
and Reed, J. C.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9238-9242[Abstract/Free Full Text]
-
Sedlak, T. W.,
Oltvai, Z. N.,
Yang, E.,
Wang, K.,
Boise, L. H.,
Thompson, C. B.,
and Korsmeyer, S. J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
7834-7838[Abstract/Free Full Text]
-
Wang, K.,
Yin, X.-M.,
Chao, D. T.,
Milliman, C. L.,
and Korsmeyer, S. J.
(1996)
Genes Dev.
10,
2859-2869[Abstract/Free Full Text]
-
Han, J., Sabbatini, P., Perez, D., Rao, L., Modha, D., and White, E. (1996) Gene Dev. 461-477
-
Chen, G.,
Branton, P. E.,
Yang, E.,
Korsmeyer, S. J.,
and Shore, G. C.
(1996)
J. Biol. Chem.
271,
24221-24225[Abstract/Free Full Text]
-
Huang, D. C. S.,
Cory, S.,
and Strasser, A.
(1997)
Oncogene
14,
405-414[CrossRef][Medline]
[Order article via Infotrieve]
-
Nava, V. E.,
Cheng, E. H.-Y.,
Veliuona, M.,
Zou, S.,
Clem, R. J.,
Mayer, M. L.,
and Hardwick, J. M.
(1997)
J. Virol.
71,
4118-4122[Abstract]
-
Cheng, E. H.-Y.,
Nicholas, J.,
Bellows, D. S.,
Hayward, G. S.,
Guo, H.-G.,
Reitz, M. S.,
and Hardwick, J. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
690-694[Abstract/Free Full Text]
-
Hockenbery, D.,
Nuñez, G.,
Milliman, C.,
Schreiber, R. D.,
and Korsmeyer, S. J.
(1990)
Nature
348,
334-336[CrossRef][Medline]
[Order article via Infotrieve]
-
Krajewski, S.,
Tanaka, S.,
Takayama, S.,
Schibler, M. J.,
Fenton, W.,
and Reed, J. C.
(1993)
Cancer Res.
53,
4701-4714[Abstract/Free Full Text]
-
Akao, Y.,
Otsuki, Y.,
Kataoka, S.,
Ito, Y.,
and Tsujimoto, Y.
(1994)
Cancer Res.
54,
2468-2471[Abstract/Free Full Text]
-
Hsu, Y.-T.,
Wolter, K. G.,
and Youle, R. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3668-3672[Abstract/Free Full Text]
-
Hsu, Y.-T.,
and Youle, R. J.
(1997)
J. Biol. Chem.
272,
13829-13834[Abstract/Free Full Text]
-
Knudson, C. M.,
Tung, K. S. K.,
Tourtellotte, W. G.,
Brown, G. A. J.,
and Korsmeyer, S. J.
(1995)
Science
270,
96-99[Abstract/Free Full Text]
-
Rodriguez, I.,
Ody, C.,
Araki, K.,
Garcia, I.,
and Vassalli, P.
(1997)
EMBO J.
16,
2262-2270[CrossRef][Medline]
[Order article via Infotrieve]
-
Shindler, K. S.,
Latham, C. B.,
and Roth, K. A.
(1997)
J. Neurosci.
17,
3112-3119[Abstract/Free Full Text]
-
Brauweiler, A.,
Garrus, J. E.,
Reed, J. C.,
and Nyborg, J. K.
(1997)
Virology
231,
135-140[CrossRef][Medline]
[Order article via Infotrieve]
-
Yin, C.,
Knudson, C. M.,
Korsmeyer, S. J.,
and Van Dyke, T.
(1997)
Nature
385,
637-640[CrossRef][Medline]
[Order article via Infotrieve]
-
Rampino, N.,
Yamamoto, H.,
Ionov, Y.,
Li, Y.,
Sawai, H.,
Reed, J. C.,
and Perucho, M.
(1997)
Science
275,
967-969[Abstract/Free Full Text]
-
Yamamoto, H.,
Sawai, H.,
and Perucho, M.
(1997)
Cancer Res.
57,
4420-4426[Abstract/Free Full Text]
-
Yang, E.,
Zha, J.,
Jockel, J.,
Boise, L. H.,
Thompson, C. B.,
and Korsmeyer, S. J.
(1995)
Cell
80,
285-291[CrossRef][Medline]
[Order article via Infotrieve]
-
Cheng, E. H.-Y.,
Levine, B.,
Boise, L. H.,
Thompson, C. B.,
and Hardwick, J. M.
(1996)
Nature
379,
554-556[CrossRef][Medline]
[Order article via Infotrieve]
-
Simonian, P. L.,
Grillot, D. A. M.,
Merino, R.,
and Nuñez, G.
(1996)
J. Biol. Chem.
271,
22764-22772[Abstract/Free Full Text]
-
Simonian, P. L.,
Grillot, D. A. M.,
Andrews, D. W.,
Leber, B.,
and Nuñez, G.
(1996)
J. Biol. Chem.
271,
32073-32077[Abstract/Free Full Text]
-
Molday, L. L.,
Cook, N. J.,
Kaupp, U. B.,
and Molday, R. S.
(1990)
J. Biol. Chem.
265,
18690-18695[Abstract/Free Full Text]
-
Hsu, Y.-T.,
and Molday, R. S.
(1993)
Nature
361,
76-79[CrossRef][Medline]
[Order article via Infotrieve]
-
Wolter, K. G.,
Hsu, Y.-T.,
Smith, C. L.,
Nechushtan, A.,
Xi, X.-G.,
and Youle, R. J.
(1997)
J. Cell Biol.
139,
1281-1292[Abstract/Free Full Text]
-
Yin, X.-M.,
Oltvai, Z. N.,
and Korsmeyer, S. J.
(1994)
Nature
369,
321-323[CrossRef][Medline]
[Order article via Infotrieve]
-
Chittenden, T.,
Flemington, C.,
Houghton, A. B.,
Ebb, R. G.,
Gallo, G. J.,
Elangovan, B.,
Chinnadurai, G.,
and Lutz, R. J.
(1995)
EMBO J.
14,
5589-5596[Medline]
[Order article via Infotrieve]
-
Elangovan, B.,
and Chinnadurai, G.
(1997)
J. Biol. Chem.
272,
24494-24498[Abstract/Free Full Text]
-
Zha, J.,
Harada, H.,
Osipov, K.,
Jockel, J.,
Waksman, G.,
and Korsmeyer, S. J.
(1997)
J. Biol. Chem.
272,
24101-24104[Abstract/Free Full Text]
-
Inohara, N.,
Ding, L.,
Chen, S.,
and Nuñez, G.
(1997)
EMBO J.
16,
1686-1694[CrossRef][Medline]
[Order article via Infotrieve]
-
Muchmore, S. W.,
Sattler, M.,
Liang, H.,
Meadows, R. P.,
Harlan, J. E.,
Yoon, H. S.,
Nettesheim, D.,
Chang, B. S.,
Thompson, C. B.,
Wong, S.-L.,
Ng, S.-C.,
and Fesik, S. W.
(1996)
Nature
381,
335-341[CrossRef][Medline]
[Order article via Infotrieve]
-
Silverman, J. A.,
Mindell, J. A.,
Finkelstein, A.,
Shen, W. H.,
and Collier, R. J.
(1994)
J. Biol. Chem.
269,
22524-22532[Abstract/Free Full Text]
-
Minn, A. J.,
Velez, P.,
Schendel, S. L.,
Liang, H.,
Muchmore, S. W.,
Fesik, S. W.,
Fill, M.,
and Thompson, C. B.
(1997)
Nature
385,
353-357[CrossRef][Medline]
[Order article via Infotrieve]
-
Antonsson, B.,
Conti, F.,
Ciavatta, A.,
Montessuit, S.,
Lewis, S.,
Martinou, I.,
Bernasconi, L.,
Bernard, A.,
Mermod, J.-J.,
Mazzei, G.,
Maundrell, K.,
Gambale, F.,
Sadoul, R.,
and Martinou, J.-C.
(1997)
Science
277,
370-372[Abstract/Free Full Text]
-
Schendel, S. L.,
Xie, A.,
Montal, M. O.,
Matsuyama, S.,
Montal, M.,
and Reed, J. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5113-5118[Abstract/Free Full Text]
-
Schlesinger, P. H.,
Gross, A.,
Yin, X. M.,
Yamamoto, K.,
Saito, M.,
Waksman, G.,
and Korsmeyer, S. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11357-11362[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:
|